Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
National Healthcare Properties, Inc. (NHPAP)
USD23.25
+0.03 (+0.15%)
US NASDAQ Real Estate REIT - Healthcare Facilities
Address
540 Madison Avenue
New York City, US
New York City, US
CEO
Michael R. Anderson
Website
healthcaretrustinc.com
IPO
2019-12-09
CIK 1561032 ISIN US42226B2043
Also trades on
NASDAQ Global Market · HTIA (USD)
NASDAQ Global Market · HTIBP (USD)
NASDAQ Global Market · NHPAP (USD)
NASDAQ Global Market · NHPBP (USD)
Other OTC · HLTC (USD)
Description
National Healthcare Properties, Inc. functions as a real estate investment trust, with its activities centered on Medical Office Buildings and Senior Housing Operating Properties. Established on October 15, 2012, the firm maintains its corporate headquarters in New York, NY.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD23.25
+0.03 (+0.15%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
14.2K
Beta
0.54
Float Shares
28.26M
Free Float %
99.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.04% | -0.22% | +7.35% | +14.32% | +20.42% | +16.59% | +57.51% | +37.12% | -9.04% | -9.88% | -9.88% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
23.25
Quality scores
Altman Z-Score
-1.17
Distress
Piotroski F-Score
5 / 9
Average
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
-
Revenue growth-3.3% Q1'26: -0.2% (vs Q1'25)
-
EPS growth+65.1% Q1'26: -50.0% (vs Q1'25)
-
FCF margin— Q1'26: +4.3% (vs Q1'25)
-
EBIT margin— Q1'26: +12.1% (vs Q1'25)
-
ROIC— Q1'26: +2.7% (vs Q1'25)
-
Share dilution+0.1% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA10.76× Q1'26: 9.29× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2026 5 Rev. Ana. 1 EPS Ana. |
Dec 2027 5 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|
| Revenue |
355.98M
329.73M – 381.58M
|
409.85M
344.74M – 518.29M
+15.1% YoY
|
482.98M
425.19M – 567.88M
+17.8% YoY
|
| EBITDA |
53.08M
49.17M – 56.90M
|
61.12M
51.41M – 77.29M
+15.1% YoY
|
72.02M
63.40M – 84.68M
+17.8% YoY
|
| EBIT |
-32.19M
-34.51M – -29.82M
|
-37.07M
-46.87M – -31.18M
-15.1% YoY
|
-43.68M
-51.36M – -38.45M
-17.8% YoY
|
| Net Income |
5.00M
4.22M – 6.14M
|
1.70M
1.43M – 2.09M
-66.0% YoY
|
6.79M
5.74M – 8.35M
+300.0% YoY
|
| SGA |
20.81M
19.27M – 22.30M
|
23.96M
20.15M – 30.29M
+15.1% YoY
|
28.23M
24.85M – 33.19M
+17.8% YoY
|
| EPS |
0.18
0.15 – 0.22
|
0.06
0.05 – 0.07
-66.0% YoY
|
0.24
0.20 – 0.29
+300.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-19.22M
OE per share TTM
-0.68
Owner's Yield
-3.03%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
2.7%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 8 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 29.2K | 0.17% |
| 2 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 2.2K | 0.17% |
| 3 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 10.9K | 0.22% |
| 4 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 6.0K | 0.22% |
| 5 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 2.4K | 0.22% |
| 6 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 265.16 | 0.22% |
| 7 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 37.31 | 0.22% |
| 8 | Vanguard Retirement Income ETF Portfolio VRIF.TO | 0.00% | 44.01 | 0.31% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
805.0K
Shares Outstanding
28.41M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael R. Anderson | President, Chief Executive Officer & Director | 3M | male |
| Andrew T. Babin | Chief Financial Officer & Treasurer | 466.7K | male |
| Jie Chai | Executive VP, General Counsel & Secretary | — | male |
| Lindsay Gordon | Executive VP & Head of Senior Housing | — | female |
| Michael Taylor | Executive Vice President of Asset Management | — | male |
| Michelle Stepinsky | Senior Vice President of Sales & Marketing | — | female |
| Ailin Park | Executive VP & Chief Accounting Officer | — | female |
| Trent Taylor | Executive Vice President of Asset Management | — | male |
| Boris Korotkin | Executive Vice President of Capital Markets & Corporate Strategy | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NHPAP
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
